Clin2
NCT06941116Possibly a fitRecruiting

Steroid test to screen for a common cause of high blood pressure

Primary AldosteronismHypertension

Part of Heart & circulation, Hormones & metabolism clinical trials.

This trial tests whether a simple steroid-based test can help identify a specific type of high blood pressure called primary aldosteronism. If you have high blood pressure that needs medication, this study may help find a treatable cause.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
406 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with high blood pressure (at least 140/90 on two different days).
  • You have been taking at least one blood pressure medication (like ACE inhibitors, ARBs, beta-blockers, calcium channel blockers, or water pills) for 4 weeks or more.
  • You do not have other known causes of high blood pressure (like kidney artery narrowing, certain tumors, or Cushing's syndrome).
  • You do not have severe heart, liver, or kidney problems, or serious infections.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03224312Recruiting
Study of primary aldosteronism in people with high blood pressure

This trial studies people with high blood pressure caused by a hormone problem called primary aldosteronism. If you qualify, the study may help doctors learn better ways to identify and manage this specific cause of blood pressure elevation.

Chongqing, Chongqing Municipality
NCT07137364Recruiting
Testing spironolactone with blood pressure drugs for PA

This trial looks at whether adding spironolactone to your current blood pressure medicines works better for people with primary aldosteronism (a condition where your adrenal glands make too much aldosterone, raising blood pressure). You may qualify if you have this form of high blood pressure but have declined surgery or don't have an adenoma.

Chongqing, Chongqing Municipality
NCT07673445Recruiting
Comparing intensive vs. standard blood pressure control for primary aldosteronism

This trial tests whether a more intensive approach to lowering blood pressure is better than standard treatment for people with primary aldosteronism (a condition where the adrenal glands make too much aldosterone, leading to high blood pressure). It aims to find which strategy reduces the risk of heart problems more effectively.

Chongqing
NCT07621458Recruiting
Primary Aldosteronism Blood Test Measurement Study

This study examines how different methods of measuring hormone levels in the blood help identify primary aldosteronism (a condition causing high blood pressure). Researchers want to find the best cutoff values to identify patients who might benefit from surgery to remove part of the adrenal gland.

Seoul, Korea, Republic of
NCT07691801Recruiting
Testing a New Method to Diagnose a Common Cause of High Blood Pressure

This study uses a new, precise blood test to help diagnose primary aldosteronism, a condition where the adrenal glands make too much of a hormone that raises blood pressure. It compares results from healthy volunteers and patients with suspected primary aldosteronism to see if it works better than current methods.

Beijing, Beijing Municipality
NCT07635134Recruiting
Testing a new method to diagnose primary aldosteronism

This study is developing a better blood test to diagnose primary aldosteronism, a condition where the adrenal glands produce too much of a hormone called aldosterone, causing high blood pressure. Researchers are comparing results from healthy volunteers and patients suspected of having this condition to find the right cutoff numbers for the new test.

Beijing, Beijing Municipality

Hear when a new Primary Aldosteronism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.